Soy protein in low protein diets increases cardioprotection in patients with CKD

December 21, 2022

1 min read

Source/Disclosures

Disclosures:
Milovanova reports no relevant financial disclosures.


We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Soy protein plus ketoanalogues of essential amino acids produced a greater effect on nephroprotection and cardioprotection in patients with stages 3b to 4 chronic kidney disease than a conventional low protein diet, researchers reported.

“Based on our results, inclusion of soy protein in the diet of patients with chronic kidney disease promotes maintenance of muscle mass, slows down estimated glomerular filtration rate decreases and diminishes left ventricle hypertrophy, augmentation index, urea, cholesterol and phosphorus serum levels,” Ludmila Yu Milovanova, PhDs, MD, professor at Sechenov First Moscow State Medical University, and colleagues wrote in Journal of Renal Nutrition.

kidney with heart

Soy protein plus ketoanalogues of essential amino acids produced a greater effect on nephroprotection and cardioprotection in patients with stages 3b to 4 chronic kidney disease than a conventional low protein diet. Source: Adobe Stock

In a prospective, randomized-controlled clinical study, researchers examined 85 patients aged 18 to65 years with CKD stages 3b to 4 who were compliant with a low protein diet in combination with ketoanalogues of essential amino acids (KA) to compare the contribution of a conventional low protein diet vs. one with primarily soy protein to nephroprotection and cardioprotection in CKD.

In a 12-month period, researchers monitored 43 patients who consumed a low protein diet with soy protein and KA, while the other 42 patients consumed a conventional low protein diet with animal protein and KA.

Researchers measured BMI, total fat and muscle mass using bioimpedance analysis to gauge nutritional status. Measurements also included eGFR, levels of calcium, phosphorous and PTH in serum, central systolic blood pressure, valve calcification, left ventricle hypertrophy and augmentation index.

Milovanova and colleagues found that substituting soy protein into a low protein diet for patients with CKD delayed decreases in eGFR (–5.9% vs. -11.3%; P = .048), as well as lean body mass in both men (0.9% vs. -11.2%; P = .017) and women (–1.8% vs. –10.3%; P = .024). Meanwhile, soy protein diets also delayed increases in left ventricular hypertrophy (4.7% vs. 12.3%; P = .042), central systolic blood pressure (2.6% vs. 13%; P = .021), augmentation index (7.6% vs. 23.3%; P = .010), phosphorus (–10.3% vs. 13%; P = .029), cholesterol (–10.7% vs. -3.4%; P = .047), urea (6.3% vs. 19.6%; P = .035) and serum levels.

“[Soy protein] may potentially substitute animal protein in patients with pre-dialysis CKD and improve nephro[protective] and cardioprotective potential of low protein diets,” Milovanova and colleagues wrote.

Leave a Comment